Loading
Azurity Pharmaceuticals
Azurity Pharmaceuticals is a privately held specialty pharmaceutical company based in Woburn, Massachusetts. Founded in 1998, the company focuses on developing and commercializing innovative medicines for patients with unmet medical needs. Azurity specializes in complex dosage forms and customized drug formulations, particularly transforming traditional tablets and capsules into patient-friendly oral liquids. The company serves a wide range of therapeutic areas, including cardiovascular, central nervous system, endocrinology, gastrointestinal, hematology, immunology, anti-infectives, oncology, and respiratory conditions. Azurity operates in over 50 countries, providing solutions for overlooked patient populations, including children and the elderly, as well as those with rare or orphan conditions. The company has expanded its capabilities through strategic acquisitions and maintains a robust pipeline of innovative pharmaceutical products.
Funding
Every round, secondary, debt facility or acquisition involving Azurity Pharmaceuticals that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$150M